MaxLinear (MXL) Tops Q2 EPS by 2c, Q3 Revenue Light

MaxLinear (NYSE: MXL) reported Q2 EPS of $0.13, $0.02 better than the analyst estimate of $0.11. Revenue for the quarter came in at $35.6 million versus the consensus estimate of $35.23 million.

MaxLinear sees FY2014 revenue of $36.5-38 million, versus the consensus of $38.1 million.

For earnings history and earnings-related data on MaxLinear (MXL) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Skechers USA (SKX) Tops Q1 EPS by 23c, Beats on Revenue; Offers FY24 Guidance
• Utah Medical Products (UTMD) Reports Q1 EPS of $1.10